EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Study of Small Intestinal Epigenomic Changes Induced by Royal Jelly

Genki Kobayashi, Takahiro Ichikawa iD, Takuro Okamura iD, Tomoyuki Matsuyama, Masahide Hamaguchi iD, Hideto Okamoto iD, Nobuaki Okumura iD, Michiaki Fukui iD

Cells · 2024

DOI: 10.3390/cells13171419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Genki Kobayashi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan. Hauptthemen laut MEDLINE: Fatty Acids, Intestine, Small, Epigenomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yamada Bee Company, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explores the impact of royal jelly (RJ) on small intestinal epigenomic changes. RJ, produced by honeybees, is known for its effects on metabolic diseases. The hypothesis is that RJ induces epigenomic modifications in small intestinal epithelial cells, affecting gene expression and contributing to metabolic health. Male db/m and db/db mice were used to examine RJ’s effects through mRNA sequencing and CUT&Tag methods. This study focused on histone modifications and gene expression changes, with statistical significance set at p < 0.05. RJ administration improved insulin sensitivity and lipid metabolism without affecting body weight. GO and KEGG pathway analyses showed significant enrichment in metabolic processes, cellular components, and molecular functions. RJ altered histone modifications, increasing H3K27me3 and decreasing H3K23Ac in genes associated with the G2M checkpoint. These genes, including Smc2, Mcm3, Ccnd1, Rasal2, Mcm6, and Mad2l1, are linked to cancer progression and metabolic regulation. RJ induces beneficial epigenomic changes in small intestinal epithelial cells, improving metabolic health and reducing cancer-associated gene expression. These findings highlight RJ’s potential as a therapeutic agent for metabolic disorders. Further research is needed to fully understand the mechanisms behind these effects and their implications for human health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty AcidsIntestine, SmallEpigenomicsAnimalsMiceMaleHistonesEpigenesis, GeneticLipid MetabolismGene Expression RegulationRoyal Jelly

Stichwörter der Autor:innen

CUT&Tagepigenomicsgenomicsmulti-omicsroyal jelly

Substanzen

Fatty AcidsHistonesRoyal Jelly

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
  • Institute for Health Science, R&D Department, Yamada Bee Company, Inc., Okayama 708-0393, Japan.

ORCID-Profile: Takahiro Ichikawa, Takuro Okamura, Masahide Hamaguchi, Hideto Okamoto, Nobuaki Okumura, Michiaki Fukui

Förderung

  • Yamada Bee Company, Inc.

Zitieren

APA

Kobayashi, G., Ichikawa, T., Okamura, T., Matsuyama, T., Hamaguchi, M., Okamoto, H., Okumura, N., & Fukui, M. (2024). A Study of Small Intestinal Epigenomic Changes Induced by Royal Jelly. Cells. https://doi.org/10.3390/cells13171419

Vancouver

Kobayashi G, Ichikawa T, Okamura T, Matsuyama T, Hamaguchi M, Okamoto H, et al. A Study of Small Intestinal Epigenomic Changes Induced by Royal Jelly. Cells. 2024. doi:10.3390/cells13171419

BibTeX
@article{Kobayashi2024,
  author = {Kobayashi, Genki and Ichikawa, Takahiro and Okamura, Takuro and Matsuyama, Tomoyuki and Hamaguchi, Masahide and Okamoto, Hideto and Okumura, Nobuaki and Fukui, Michiaki},
  title = {A Study of Small Intestinal Epigenomic Changes Induced by Royal Jelly},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13171419}
}
Kostenlos starten →